Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NewGenIvf GroupNIVF -9.09%14 Current Ratio is 3.12 as of Dec. 2025, which is 167% above its 10-year median of 1.17. GuruFocus rates NIVF with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 679 Healthcare Providers & Services companies, NewGenIvf Group ranks better than 79.09% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. NewGenIvf Group's current ratio for the quarter that ended in Dec. 2025 was 3.12.
NewGenIvf Group has a current ratio of 3.12. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for NewGenIvf Group's Current Ratio or its related term are showing as below:
NIVF'
s Current Ratio Range Over the Past 10 Years
Min: 0.4 Med: 1.17 Max: 3.12
Current: 3.12
During the past 5 years, NewGenIvf Group's highest Current Ratio was 3.12. The lowest was 0.40. And the median was 1.17.
NIVF's Current Ratio is ranked better than 79.09% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs NIVF: 3.12
NewGenIvf Group (NAS:NIVF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
NewGenIvf Group Current Ratio Related Terms
NewGenIvf Group Current Ratio Historical Data
* Premium members only.
The historical data trend for NewGenIvf Group's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NIVF vs RHEP, XCRT, SYRA: Current Ratio Comparison
For the Medical Care Facilities subindustry, NewGenIvf Group's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NewGenIvf Group Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's Current Ratio distribution charts can be found below:
* The bar in red indicates where NewGenIvf Group's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NewGenIvf Group (NIVF) has a Current Ratio of 3.12 as of Dec. 2025. This is 167% above median its historical median of 1.17. Over the past decade, NewGenIvf Group's Current Ratio has ranged from 0.40 to 3.12. According to the industry distribution chart, NewGenIvf Group ranks #142 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 20.9%.
Is NewGenIvf Group's Current Ratio too high?
NewGenIvf Group's current Current Ratio of 3.12 is 167% above median its 10-year median of 1.17. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 3.12. The Healthcare Providers & Services industry median Current Ratio is 1.47. NewGenIvf Group's value of 3.12 is 112.2% above this industry median. Based on the distribution chart, NewGenIvf Group ranks #142 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, NewGenIvf Group has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does NewGenIvf Group's Current Ratio compare to RHEP and XCRT?
According to the Healthcare Providers & Services industry distribution chart, NewGenIvf Group ranks #142 out of 679 companies for Current Ratio. This places NewGenIvf Group in the top 21% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.47. NewGenIvf Group's value of 3.12 is 112.2% above this benchmark. Historically, NewGenIvf Group's own Current Ratio has ranged from 0.40 to 3.12 over the past decade. While the company's 10-year median is 1.17 vs. the industry median of 1.47, NewGenIvf Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NewGenIvf Group's current Current Ratio of 3.12 is 112.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NewGenIvf Group's current Current Ratio is 3.12, which is 167% above median its own 10-year median of 1.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewGenIvf Group stock overvalued right now?
NewGenIvf Group (NIVF) has a current Current Ratio of 3.12. The current Current Ratio is 3.12, which is 167% above median its 10-year median of 1.17 and 112.2% above the Healthcare Providers & Services industry median of 1.47. NewGenIvf Group's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For NewGenIvf Group (NIVF), the current Current Ratio is 3.12 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
14GF Score
Get the complete analysis for NIVF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NIVF has been successfully added to your 
